Eccogene Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Eccogene Inc.
Quantité totale PI 12
Rang # Quantité totale PI 134 446
Note d'activité PI 2/5.0    12
Rang # Activité PI 75 298
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

9 2
0 0
0 1
0
 
Dernier brevet 2025 - Ssao inhibitors and use thereof
Premier brevet 2020 - Ssao inhibitors and use thereof
Dernière marque 2026 - TRANDD
Première marque 2024 - EG ECCOGENE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2026 P/S Research and development of pharmaceutical drugs; medical, scientific, and clinical research all...
2025 P/S Research and development in the field of pharmaceutical drugs; Medical and scientific research in...
Invention Thyroid hormone receptor agonists and use thereof. The application relates to a compound of Form...
Invention Ssao inhibitors and use thereof. The application relates to a compound of Formula (I′) or (I): ...
2024 P/S Pharmaceutical preparations for the treatment of obesity, cardiometabolic conditions, and inflamm...
Invention Substituted imidazoles as glp-1 receptor agonists. The application relates to a compound of Form...
2023 Invention Thyroid hormone receptor agonists and use thereof. The application relates to a compound of Formu...
2022 Invention Ssao inhibitors and use thereof. The application relates to a compound of Formula (I′) or (I): ...
2021 Invention Substituted imidazoles as glp-1 receptor agonists. The application relates to a compound of Formu...